Patrick Collombat, Ph.D.
French National Institute of Health and Medical Research (Inserm)
“It is a fantastic opportunity that we have here. We have pretty much arrived at the limit of what we can learn from animal models, and now we are starting clinical trials to check whether this approach can truly help type 1 diabetes patients. It’s really exciting.”